CHPM · Chp Merger Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - |
| SG&A | - | $536.3K | $606.5K | $291.0K | - | $140.8K | $146.8K | $165.1K | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - |
| Operating Income | - | ($536.3K) | ($606.5K) | ($291.0K) | - | ($140.8K) | ($146.8K) | ($165.1K) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - |
| Income Tax | - | $0 | $0 | $0 | - | $8.2K | $132.3K | $230.5K | - |
| Net Income | - | $7.75M | ($3.12M) | $18.04M | - | ($59.9K) | $400.9K | $751.9K | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $98.6K | $380.6K | $556.1K | $239.8K | $604.2K | $0 | $1.12M | $1.30M | - |
| Accounts Receivable | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - |
| Current Assets | $401.2K | $415.0K | $632.3K | $357.8K | $604.2K | $814.9K | $1.20M | $1.40M | - |
| Total Assets | $188.79M | $302.08M | $302.29M | $302.72M | $302.93M | $303.07M | $303.37M | $302.85M | - |
| Current Liabilities | $4.25M | $851.3K | $532.2K | $379.7K | $335.2K | $343.1K | $576.4K | $193.8K | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $25.70M | $24.00M | $31.96M | $29.28M | $10.84M | $10.84M | $11.08M | $10.96M | - |
| Stockholders' Equity | ($24.26M) | ($21.93M) | $5.00M | $5.00M | $5.00M | $23.6K | $5.00M | $5.00M | ($25.84M) |
| Retained Earnings | ($24.26M) | ($21.93M) | ($4.55M) | ($1.43M) | $1.14M | $1.28M | $1.34M | $184.5K | ($634.8K) |
Cash Flow
| Line item | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | ($364.4K) | - | $0 | - | ($142.0K) | - |
| Investing Cash Flow | - | - | - | $0 | - | $0 | - | $84.4K | - |
| Financing Cash Flow | - | - | - | - | - | $25.0K | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross margin | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | 0.0% | - | 0.0% | - | - | 24.8% | 23.5% | - |
| Return on assets | - | 2.6% | -1.0% | 6.0% | - | -0.0% | 0.1% | 0.2% | - |
| Return on equity | - | -35.3% | -62.4% | 360.9% | - | -254.3% | 8.0% | 15.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - |
| Liquidity | |||||||||
| Current ratio | 0.09 | 0.49 | 1.19 | 0.94 | 1.80 | 2.38 | 2.08 | 7.25 | - |
| Quick ratio | 0.09 | 0.49 | 1.19 | 0.94 | 1.80 | 2.38 | 2.08 | 7.25 | - |
| Cash ratio | 0.02 | 0.45 | 1.04 | 0.63 | 1.80 | 0.00 | 1.95 | 6.72 | - |
| Leverage | |||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - |
| Equity multiplier | -7.78 | -13.78 | 60.46 | 60.54 | 60.59 | 12866.68 | 60.67 | 60.57 | - |
| Liabilities / Assets | 0.14 | 0.08 | 0.11 | 0.10 | 0.04 | 0.04 | 0.04 | 0.04 | - |
| Efficiency | |||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - |
| Valuation | |||||||||
| P / E | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - |
| Growth | |||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | -280.8% | -313.1% | -76.2% | - | - | - | - | - |
| Net income growth (YoY) | - | - | - | 2299.6% | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | -0.0% | -0.0% | - | - | - | - | - |
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing CHP Merger Corp. against the 5 most active filers in the same SIC group.